Who bought keryx?

Who bought keryx?

Akebia Therapeutics
Kidney disease specialist Akebia Therapeutics will merge with Boston-based Keryx Biopharmaceuticals in an all-stock deal, creating a $1 billion company that blends Keryx’s small commercial presence on the renal market with Akebia’s development pipeline.

How many employees does Akebia Therapeutics have?

Company Growth (employees)

Employees (est.) (Dec 2018) 324 (+187%)
Website Visits (Aug 2021) 5.4 k
Revenue (FY, 2020) $295.3 M (-11%)
Share Price (Dec 2021) $2.5 (-1%)
Cybersecurity rating B More

How do you install keryx?

Installing packages on base system Click on Projects –> Install Packages. A window will open, which lists packages on the pen drive. You can select which packages to install, and click Continue. Keryx will install the packages onto your base system.

Is Vadadustat approved by FDA?

The US Food and Drug Administration has accepted for filing the New Drug Application (NDA) for vadadustat in the treatment of anemia due to chronic kidney disease (CKD) in both adult patients on dialysis and adult patients not on dialysis.

How do I run keryx on Ubuntu?

1 Answer

  1. Download keryx portable.
  2. Extract the Downloaded file.
  3. goto ../Downloads/keryx_1.0-public21_portable/bin.
  4. Double click on keryx.py and choose run/run in terminal.

What is apt offline?

apt-offline brings offline package management functionality to Debian based system. It can be used to download packages and its dependencies to be installed later on (or required to update) a disconnected machine. It can also fetch bug reports for the packages that are downloaded.

How do I put offline offline in an apartment?

At the disconnected computer, insert the USB flash drive navigate to the directory on the flash drive containing the two files, enter sudo apt-offline install bundle. zip . Once it completes your repositories will be updated, you can then install the upgrades by entering: sudo apt-get upgrade .

Is Keryx Biopharmaceuticals the right stock to buy now?

Wall Street analysts have given Keryx Biopharmaceuticals a “N/A” rating, but there may be better buying opportunities in the stock market. Some of MarketBeat’s past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Keryx Biopharmaceuticals wasn’t one of them.

How much money does keykeryx biopharmaceuticals make a year?

Keryx Biopharmaceuticals has a market capitalization of $344.00 million and generates $60.64 million in revenue each year. The biopharmaceutical company earns $-163,440,000.00 in net income (profit) each year or ($0.88) on an earnings per share basis.

What is the difference between Keryx and Vadadustat?

Keryx is no longer listed for trading on The Nasdaq Capital Market . Vadadustat is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) currently in global Phase 3 development for the treatment of anemia due to chronic kidney disease.

What happens to shareholders of Keryx after the merger with akebia?

As previously announced, Keryx shareholders are entitled to receive 0.37433 common shares of Akebia for each common share of Keryx they own. The combined company will be Akebia Therapeutics, Inc., which will continue to trade on The Nasdaq Global Market under the ticker symbol AKBA.

https://www.youtube.com/watch?v=2__FCsPVKEY

author

Back to Top